Biotechnology Ultrasector Financials
| BIPSX Fund | USD 21.25 0.42 1.94% |
Biotechnology |
Please note that you must use caution to infer results of funds future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.
Biotechnology Ultrasector Fund Summary
Biotechnology Ultrasector competes with Biotechnology Ultrasector, Internet Ultrasector, Health Care, Ultranasdaq-100 Profund, and Pharmaceuticals Ultrasector. The fund invests in financial instruments that the fund advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index represents the biotechnology segment of the SP Total Market Index, which comprises the following sub-industry biotechnology. The fund is non-diversified.Specialization | Trading--Leveraged Equity, Large |
| Instrument | USA Mutual Fund View All |
| Exchange | NMFQS Exchange |
| Business Address | Profunds |
| Mutual Fund Family | ProFunds |
| Mutual Fund Category | Trading--Leveraged Equity |
| Benchmark | Dow Jones Industrial |
| Phone | 888 776 3637 |
| Currency | USD - US Dollar |
Biotechnology Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biotechnology Ultrasector's current stock value. Our valuation model uses many indicators to compare Biotechnology Ultrasector value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biotechnology Ultrasector competition to find correlations between indicators driving Biotechnology Ultrasector's intrinsic value. More Info.Biotechnology Ultrasector Profund is fourth largest fund in price to earning among similar funds. It is second largest fund in price to book among similar funds fabricating about 3.20 of Price To Book per Price To Earning. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotechnology Ultrasector's earnings, one of the primary drivers of an investment's value.Biotechnology Ultrasector Systematic Risk
Biotechnology Ultrasector's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Biotechnology Ultrasector volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Biotechnology Ultrasector correlated with the market. If Beta is less than 0 Biotechnology Ultrasector generally moves in the opposite direction as compared to the market. If Biotechnology Ultrasector Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Biotechnology Ultrasector is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Biotechnology Ultrasector is generally in the same direction as the market. If Beta > 1 Biotechnology Ultrasector moves generally in the same direction as, but more than the movement of the benchmark.
Biotechnology Ultrasector March 28, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biotechnology Ultrasector help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biotechnology Ultrasector Profund. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biotechnology Ultrasector Profund based on widely used predictive technical indicators. In general, we focus on analyzing Biotechnology Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biotechnology Ultrasector's daily price indicators and compare them against related drivers.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 38.77 | |||
| Value At Risk | (4.06) | |||
| Potential Upside | 2.91 |
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Ultrasector financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Ultrasector security.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |